← Back to Dashboard

DRREDDY Dr. Reddy's Laboratories Ltd. — Smart-Money Activity, F&O Buildup & Bulk Deals

Sector: Healthcare · Nifty 50 Weight: 0.77%
₹ 1,263.30
-0.84%

Smart Money Verdict synthesis of derivatives, deals, and promoter files

Derivatives signal Long Unwinding
Longs are exiting (OI down -2.3%) as price declines (-0.8%), indicating lack of holding support.

Analysis what the data is telling us about DRREDDY

In the last completed session, Dr. Reddy's Laboratories Ltd. closed -0.84% with futures open interest moving -2.3%. That combination — price falling while OI shrinks — is classified as Long Unwinding. Existing longs are exiting rather than new shorts being added; the move down lacks the conviction of fresh selling. The stock's option PCR sits at 0.54, indicating heavy call-side writing — option dealers see resistance overhead. Max-pain strike at ₹1,300 sits 2.9% above the current price, a mild magnet near expiry.

There have been no notable bulk or block deals from FIIs, mutual funds, or insurance companies in Dr. Reddy's Laboratories Ltd. over the last 30 sessions.

Putting it together, the smart-money picture for Dr. Reddy's Laboratories Ltd. leans cautious into the next session.

F&O Positioning EOD derivatives setup

Buildup Class
Long Unwinding
bias: bearish
Futures OI
15,703,125
-368750 (-2.3%)
Option PCR (OI)
0.54
heavy call writing
Max Pain Strike
₹ 1,300
writer loss minimized strike

Quote Details key metrics & weights

Previous Close
₹ 1,274.00
yesterday's EOD close
Index Contribution
-0.006 pp
contribution to Nifty
Traded Volume
1,226,407
live shares traded today
Upcoming Earnings
no report scheduled

Key Fundamentals headline ratios · Healthcare

P/E (TTM)
24.5
price / earnings
P/B
2.8
price / book
ROE
11.8%
return on equity
Market Cap
₹ 105,164 Cr
total market value
Dividend Yield
0.63%
trailing yield
EPS (TTM)
₹ 51.47
earnings per share

Fundamental ratios sourced from public market data, refreshed periodically; verify against company filings before relying on them.

Institutional Deals last 30 sessions (bulk & block)

No institutional bulk or block deals recorded for this stock in the last 30 sessions.

Insider & Promoter Filings last 60 days

No insider disclosures filed for this stock in the last 60 days.

Option Chain Ladder nearest expiry 2026-06-30 · spot 1,263 · EOD 2026-06-03

Option writers expect range between 1,200 and 1,350+6.9% upside, -5.0% downside.
roughly symmetric
Call OI (writers) Strike Put OI (writers)
13,125 +0k
IV 31% Δ 0.76 θ -0.8 ν 1
1200 S
748,125 +11k
IV 23% Δ -0.18 θ -0.3 ν 1
0
IV 103% Δ 0.62 θ -2.6 ν 1
1210
36,875 -4k
IV 23% Δ -0.21 θ -0.4 ν 1
15,625
IV 41% Δ 0.66 θ -1.1 ν 1
1220
101,875
IV 23% Δ -0.25 θ -0.4 ν 1
1,250
IV 53% Δ 0.61 θ -1.4 ν 1
1230
38,750 +2k
IV 23% Δ -0.29 θ -0.4 ν 1
625
IV 39% Δ 0.61 θ -1.1 ν 1
1240
62,500 +5k
IV 22% Δ -0.34 θ -0.4 ν 1
19,375 +8k
IV 26% Δ 0.60 θ -0.8 ν 1
1250
158,125 +14k
IV 22% Δ -0.39 θ -0.5 ν 1
63,750 +42k
IV 26% Δ 0.56 θ -0.8 ν 1
1260
181,250 +76k
IV 22% Δ -0.44 θ -0.5 ν 1
80,625 +30k
IV 25% Δ 0.51 θ -0.8 ν 1
1270
135,625 +25k
IV 22% Δ -0.49 θ -0.4 ν 1
210,625 +86k
IV 25% Δ 0.47 θ -0.7 ν 1
1280
94,375 -6k
IV 22% Δ -0.54 θ -0.4 ν 1
71,250 +3k
IV 25% Δ 0.42 θ -0.7 ν 1
1290
108,125 +6k
IV 21% Δ -0.60 θ -0.4 ν 1
576,875 +57k
IV 25% Δ 0.37 θ -0.7 ν 1
1300 MP
313,750 -12k
IV 21% Δ -0.65 θ -0.3 ν 1
90,625 +31k
IV 25% Δ 0.33 θ -0.6 ν 1
1310
70,625
IV 21% Δ -0.70 θ -0.3 ν 1
375,000 +59k
IV 25% Δ 0.29 θ -0.6 ν 1
1320
278,125
IV 10% Δ -0.92 θ +0.1 ν 1

Chain Interpretation

Spot Underlying 1,263.30
Key Resistance (R) 1,350
Key Support (S) 1,200
Max Pain Strike (MP) 1,300
Concentrations of Option open interest show strong barrier levels. Option writers defend these levels, especially heading into monthly derivatives expiry.

Strategy Builder multi-leg payoff for DRREDDY options · 2026-06-30 expiry

Underlying: DRREDDY · Spot: ₹ 1,263.30 · Expiry: 2026-06-30 · Lot: 625

Legs

Side
Type
Strike
Qty
Premium
Net premium
Max profit
Max loss
Breakevens
Position Delta
Position Theta/day
Position Vega/1% IV

Payoff at expiry

Latest News recent coverage from Reuters, Simply Wall St, MT Newswires and others